NDA 008951

LILLY

FDA Drug Application

Application #008951

Application Sponsors

NDA 008951

LILLY

Marketing Status

• Discontinued: 001
• Discontinued: 002

Application Products

001	TABLET;ORAL	1.25MG	0	PAGITANE	CYCRIMINE HYDROCHLORIDE
002	TABLET;ORAL	2.5MG	0	PAGITANE	CYCRIMINE HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular Entity

ORIG

1

AP

1953-07-22

STANDARD

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 8951
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)